Ignite Creation Date:
2024-05-06 @ 9:41 AM
Last Modification Date:
2024-10-26 @ 12:18 PM
Study NCT ID:
NCT03047083
Status:
COMPLETED
Last Update Posted:
2022-01-26
First Post:
2017-02-06
Brief Title:
Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia AML With or Without FMS-like Tyrosine Kinase-3 FLT3 Mutation Study Based on Retrospective Chart Review
Sponsor:
Astellas Pharma Global Development Inc
Organization:
Astellas Pharma Inc